ReviewPharmaceutics2024

Recent Advances in Drug Delivery Strategies for High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Brief Review from 2018 to 2024.

Feng Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.